Abstract
1. Levels of insulin-signalling molecules are altered in streptozotocin (STZ)-induced diabetes, a model of Type 1 diabetes. However, the tissue-specific regulation of these changes and the effect of insulin supplementation on signalling molecule protein levels have not been well characterized. 2. In the present study, we evaluated the level of proximal insulin-signalling intermediates in the heart and in red and white gastrocnemius muscles of 2 week diabetic rats and diabetic rats supplemented with insulin. 3. Diabetes augmented levels of the insulin receptor and the p85 regulatory subunit of phosphatidylinositol 3-kinase in the red gastrocnemius, but not in the white gastrocnemius or the heart. Furthermore, diabetes reduced insulin receptor substrate-1 levels in both the red and white gastrocnemius, but not in the heart. Examination of the levels and basal activities of distal insulin-signalling intermediates (protein kinase B (PKB)/Akt, extracellular signal-regulated kinase (ERK) 1/2, p38 mitogen-activated protein kinase (MAPK)) also failed to reveal a specific pattern in these changes. Thus, diabetes reduced basal ERK1/2 and PKB/Akt phosphorylation in the heart and white gastrocnemius, respectively, whereas it augmented basa...Continue Reading
References
Oct 1, 1992·Endocrinology·L CoderreP F Pilch
Jul 4, 1991·Nature·X J SunM F White
Feb 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·N B RudermanL C Cantley
Oct 1, 1982·Canadian Journal of Physiology and Pharmacology·V Chen, C D Ianuzzo
Sep 1, 1984·The Journal of Clinical Endocrinology and Metabolism·H Yki-Järvinen, V A Koivisto
Nov 1, 1984·The American Journal of Anatomy·R B Armstrong, R O Phelps
Aug 1, 1981·Diabetes·A BonenW M Watson-Wright
Dec 1, 1981·Diabetes·R A DeFronzoJ P Felber
Jan 1, 1993·Heart and Vessels·M NakaoN Sakamoto
May 1, 1993·Diabetes·M G Myers, M F White
Jun 1, 1997·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·L Yenush, M F White
Jul 21, 1997·FEBS Letters·O BossJ P Giacobino
Aug 4, 1997·The American Journal of Cardiology·C Meyer, M Schwaiger
Dec 17, 1998·The Journal of Endocrinology·K GrzelkowskaJ Grizard
Jan 14, 1999·Endocrinology·J F MarkunsL J Goodyear
Mar 6, 1999·Endocrinology·P H WangR J Smith
Mar 17, 1999·Diabetes·T G KurowskiN B Ruderman
Mar 17, 1999·Diabetes·X M SongJ R Zierath
Apr 2, 1999·Diabetes·F GiorginoR J Smith
Jun 24, 2000·Proceedings of the Society for Experimental Biology and Medicine·S HidakaT Sakata
Jul 11, 2000·Journal of Molecular and Cellular Cardiology·C DepreH Taegtmeyer
Nov 28, 2001·Diabetes·Y BoirieK S Nair
Nov 28, 2001·Diabetes·L LaviolaF Giorgino
Apr 10, 2002·Circulation·Heinrich TaegtmeyerMartin E Young
Oct 24, 2002·The Journal of Biological Chemistry·Romel SomwarAmira Klip
Jun 28, 2003·FEBS Letters·Anne M JohnstonEmmanuel Van Obberghen
Jul 3, 2003·American Journal of Physiology. Endocrinology and Metabolism·Stephen J CrozierLeonard S Jefferson
Jul 28, 2005·Diabetes·Gautam K BandyopadhyayJerold M Olefsky
Sep 9, 2006·Endocrinology and Metabolism Clinics of North America·Jatin K Dave, Vikram V Kamdar
Citations
Jul 14, 2010·Antioxidants & Redox Signaling·Jakob Vinten-JohansenKarin Przyklenk
Aug 21, 2012·PloS One·Laura NocitoJoan J Guinovart
Sep 24, 2010·Pediatric Diabetes·Matthew P KrauseThomas J Hawke
Jul 14, 2012·Differentiation; Research in Biological Diversity·Zoe Redshaw, Paul T Loughna
May 6, 2011·Drugs & Aging·Karin Przyklenk
Jan 16, 2009·Biochemical Society Transactions·Deborah C I Goberdhan, C A Richard Boyd
Nov 10, 2011·American Journal of Physiology. Endocrinology and Metabolism·Juha J HulmiHeikki Kainulainen
Oct 3, 2018·PloS One·Yunxia LiHongfang Li